Human serum paraoxonase (PON1) concentration predicts cardiovascular disease in diabetic patients

被引：0
|
作者：
Inoue, M. [1 ]
Ikeda, Y. [1 ]
Suehiro, T. [1 ]
Takata, H. [1 ]
Inada, S. [1 ]
Ogami, N. [1 ]
Osaki, F. [1 ]
Arii, K. [1 ]
Hashimoto, K. [1 ]
机构：
[1] Kochi Univ, Sch Med, Nankoku, Kochi, Japan
来源：
ATHEROSCLEROSIS SUPPLEMENTS | 2006年 / 7卷 / 03期
关键词：
D O I：
10.1016/S1567-5688(06)81393-0
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
WeP1137
引用
收藏
页码：354 / 354
页数：1
相关论文
共 50 条
  • [1] Some cardiovascular therapeutics inhibit paraoxonase 1 (PON1) from human serum
    Isgor, Mehmet Mustafa
    Beydemir, Sukru
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2010, 645 (1-3) : 135 - 142
  • [2] Paraoxonase (Pon1) Q192R polymorphism and serum Pon1 activity in diabetic patients on maintenance hemodialysis
    Zhang, B
    Eto, S
    Fan, P
    Bian, C
    Shimoji, E
    Saito, T
    Saku, K
    CLINICAL NEPHROLOGY, 2003, 60 (04) : 257 - 265
  • [3] Human serum paraoxonase concentration predicts cardiovascular mortality in hemodialysis patients
    Ikeda, Y.
    Suehiro, T.
    Itahara, T.
    Inui, Y.
    Chikazawa, H.
    Inoue, M.
    arii, K.
    Hashimoto, K.
    CLINICAL NEPHROLOGY, 2007, 67 (06) : 358 - 365
  • [4] Serum paraoxonase 1 (PON1) measurement: an update
    Ceron, Jose J.
    Tecles, Fernando
    Tvarijonaviciute, Asta
    BMC VETERINARY RESEARCH, 2014, 10
  • [5] Promoter polymorphisms of human paraoxonase PON1 gene and serum paraoxonase activities and concentrations
    Leviev, I
    James, RW
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2000, 20 (02) : 516 - 521
  • [6] Evaluation of paraoxonase and arylesterase activity of serum PON1 in patients with acute heart disease
    Yordanova, K.
    Emin, Sinan
    Doneva, Krastina
    Tsoneva, Vanya
    Dimov, Dimo
    Kamenova, Zdravka
    Vlaykova, Tatyana
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2009, 14 : 122 - 123
  • [7] Serum paraoxonase 1 (PON1) measurement: an update
    Jose J Ceron
    Fernando Tecles
    Asta Tvarijonaviciute
    BMC Veterinary Research, 10
  • [8] Further characterization of human serum paraoxonase (PON1) lactonase activity
    Billecke, S
    Draganov, D
    Counsell, R
    Stetson, P
    Watson, C
    Hsu, C
    La Du, BN
    FASEB JOURNAL, 2000, 14 (08): : A1323 - A1323
  • [9] Paraoxonase-1 (PON1) promoter region polymorphisms, serum PON1 status and coronary heart disease
    Mackness, Bharti
    Turkie, Wajdi
    Mackness, Mike
    ARCHIVES OF MEDICAL SCIENCE, 2013, 9 (01) : 8 - 13
  • [10] Naringenin is an inhibitor of human serum paraoxonase (PON1): An in vitro study
    Mahrooz, Abdolkarim
    Rashidi, Mohammad-Reza
    Nouri, Mohammad
    CLINICAL BIOCHEMISTRY, 2011, 44 (13) : S249 - S249
12345